The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Garfield Alastair since 2025.
This trader's CIK number is 2027261.
At the time of last reporting, Garfield Alastair was the Chief Scientific Officer of Rhythm Pharmaceuticals, Inc.. (stock ticker symbol RYTM).
Also see all insider trading activities at Rhythm Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RYTM | 0 | $0 | 1,319 | $85,345 | 4,445 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-02 | RYTM | Sale | 1,319 | 64.70 | 85,345 |
| 2025-07-01 | RYTM | Option Ex | 4,445 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Garfield Alastair (Chief Scientific Officer of Rhythm Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.